Trial Profile
A clinical trial of adjunctive Celecoxib treatment in patients with major depression: a double-blind, placebo controlled trial.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Fluoxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 05 Apr 2012 Additional lead trial centre identified as reported by Iranian Registry of Clinical Trials.
- 05 Apr 2012 Trial phase changed from III to II/III as reported by Iranian Registry of Clinical Trials.
- 05 Apr 2012 Planned end date (20 Apr 2009) added as reported by Iranian Registry of Clinical Trials.